Accutane
Correspondence
October 6, 2000
Letter from Dr. Russell Ellison, V.P. Medical Affairs, Roche Laboratories, to Representative Bart Stupak.
October 11, 2000
Response from Representative Bart Stupak to Dr. Russell Ellison, V.P. Medical Affairs, Roche Laboratories.
October 11, 2000
Letter from Representatives Bart Stupak (D-MI), Henry Waxman (D-CA), Tom Barrett (D-WI), Sherrod Brown (D-OH), Marge Roukema (R-NJ), Tom Coburn, M.D. (R-OK), Representative Zach Wamp (R-TN), Representative Ed Bryant (R-TN) to Patrick Zenner, President and Chief Executive Officer, Hoffman-LaRoche Inc.
October 11, 2000
Letter from Representatives Bart Stupak (D-MI), Henry Waxman (D-CA), Tom Barrett (D-WI), Sherrod Brown (D-OH), Marge Roukema (R-NJ), Tom Coburn, M.D. (R-OK), Representative Zach Wamp (R-TN), Representative Ed Bryant (R-TN) to Jane Henney, Commissioner Food and Drug Administration.
October 17, 2000
Response from Patrick Zenner, President and Chief Executive Officer, Hoffman-LaRoche Inc. to Representative Stupak.
November 13, 2000
Letter from Patrick J. Zenner, President and Chief Executive Officer, Hoffman-LaRoche Inc. to Representative Stupak regarding Hoffman LaRoche plans for revised Informed Consent and Medication Guide. (PDF - 37 pages 2435KB)
November 14, 2000
Response from Melinda Plaisier, Associate Commissioner for Legislation. (PDF - 2 pages 145KB)
January 9, 2001
Letter from Dr. Janet Woodcock, Director for the Center for Drug Evaluation and Research to Consumer/Healthcare Providers regarding inquiries about Accutane to the FDA. (PDF - 2 pages 97KB)
March 1, 2001
Letter from Representative Bart Stupak to Dr. Janet Woodcock, Director for the Center for Drug Evaluation and Research to Consumer/Healthcare Providers. (PDF - 2 pages 94KB)
May 25, 2001
Letter from Representative Bart Stupak to Dr. Janet Woodcock, Director for the Center for Drug Evaluation and Research to Consumer/Healthcare Providers, regarding reports of additional suicides. (PDF - 2 pages 108KB)
May 25, 2001
Letter from Representative Bart Stupak to Dr. Janet Woodcock, Director for the Center for Drug Evaluation and Research to Consumer/Healthcare Providers, regarding independent scientific study. (PDF - 3 pages 285KB)
December 20, 2001
Letter to Representative Bart Stupak from Melinda K. Plaisier, Associate Commissioner for Legislation, Food and Drug Administration. (PDF - 3 pages 116KB)
January 4, 2002
Letter from Representative Bart Stupak to Dr. Janet Woodcock, Director for the Center for Drug Evaluation and Research to Consumer/Healthcare Providers, regarding independent scientific study. (PDF - 1 page 57KB)
